This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:


peer-reviewed publication


Novel strategy for ultrahigh density copper single atom enzymes developed for tumor therapies

Novel strategy for ultrahigh density copper single atom enzymes developed for tumor therapies
Schematic illustration showing the preparation process of Cu SAEs. Credit: Liu Hongji

A research group led by Prof. Wang Hui and Prof. Zhang Xin from the Hefei Institutes of Physical Science of the Chinese Academy of Sciences introduced a new strategy to prepare ultrahigh density copper single-atom enzymes for tumor self-cascade catalytic therapy.

"The powerful enzymes can help to fight tumors," said Dr. Liu Hongji, a member of the research team.

The study is published in Chemical Engineering Journal.

The low-valence Cu single atom enzymes (Cu SAEs) contribute to alleviating the inefficient generation of ·OH dilemma in the , especially in the presence of overexpressed glutathione (GSH). However, the conveniently controlled synthesis of Cu SAEs with high atom remains a challenging task due to the cumbersome process, compositional heterogeneity, poor water solubility, and uncontrollable metal valence.

To solve this dilemma, the researchers proposed a well-controlled one-step solvent self-carbonization-reduction strategy to fabricate Cu SAEs with ultrahigh atomic density. Formamide can easily be condensed into a linear macromolecular chain for chelating Cu because of its high N content and vacant ligand sites. The resultant carbon nitride-based fragments reduce Cu to Cu.

"The obtained Cu SAEs has an incredibly high density of 23.36 wt. %, surpassing previously reported metal- or carbon-based supported Cu single-atom catalysts," explained Liu.

This comes from the well-defined Cu species, whereas aberration-corrected scanning and the X-ray absorption fine structure spectroscopy corroborate the Cu species existed in the form of single atoms.

"The Cu SAEs showed remarkable self-cascade catalytic activities, leading to a inhibition rate up to 89.17 %," he added.

This study provides a novel strategy for fabricating valence-controlled SAEs supported on C3N4 for catalytic applications, according to the team.

More information: Hongji Liu et al, Ultrahigh density copper (Ⅰ) single atom enzymes for tumor self-cascade catalytic therapy, Chemical Engineering Journal (2023). DOI: 10.1016/j.cej.2023.148273

Journal information: Chemical Engineering Journal

Provided by Hefei Institutes of Physical Science, Chinese Academy of Sciences

Citation: Novel strategy for ultrahigh density copper single atom enzymes developed for tumor therapies (2024, January 19) retrieved 23 April 2024 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

NT-proBNP does not improve evaluation of syncope in the ED


Feedback to editors